Heparin Market - Size, Share, Outlook, and
Opportunity Analysis, 2018 - 2026
Heparin is used to prevent or treat certain blood vessel, heart, and lung conditions. It is also
used in blood transfusion, blood samplings during prophylaxis treatment, and for treatment of
blood clotting disorders Heparin may be used to diagnose and treat a serious blood condition
called disseminated intravascular coagulation. Heparin is sometimes used alone or in
combination with aspirin to prevent pregnancy loss and other problems.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/2602
The global heparin market size was valued at US$ 9.4 billion in 2017 and is expected to
witness a CAGR of 5.1% over the forecast period (2018 – 2026).
Market Dynamics
Rising cases of conditions such as coronary heart disease, pulmonary embolism, and deep vein
thrombosis is one of the major factors for increased demand of heparin drugs in the market.
Myocardial infarction (MI) is one of the major complications of coronary heart disease.
According to the American Heart Association 2018 report, coronary heart disease is the leading
cause (43.8%) of deaths due to cardiovascular disease in the U.S., followed by stroke (16.8%).
As per the Centres for Disease Control and Prevention (CDC) 2015 report, deep vein thrombosis
affects nearly 900,000 individuals in the U.S. each year.
Despite major applications in chronic conditions, heparin is poorly absorbed by the intestine,
therefore it must be given intravenously or subcutaneously. Moreover, the drug creates a
significant risk of excessive bleeding due to anticlotting effect. Heparin also induce conditions
such as thrombocytopenia (reduced number of circulating platelets) and hypersensitivity
reactions. These factors can hamper the heparin market, during the forecast period.
Increasing incidences of coronary heart disease, pulmonary embolism, and deep vein thrombosis
is expected to drive growth of the heparin market
Heparin is widely used clinically for dialysis, deep vein thrombosis (DVT) treatment, and most
cardiac surgeries. It is also used to prevent blood clotting during open-heart surgery, kidney